Follow this preprint
Environmental sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during a coronavirus disease (COVID-19) outbreak aboard a commercial cruise ship
Motoi Suzuki, Hajime Kamiya, Kiyoko Okamoto, View ORCID ProfileTakuya Yamagishi, Kensaku Kakimoto, Makoto Takeda, Syutoku Matsuyama, Kazuya Shirato, Naganori Nao, Hideki Hasegawa, Tsutomu Kageyama, Ikuyo Takayama, Shinji Saito, Takaji Wakita, Makoto Ohnishi, Koji Wada, Retsu Fujita, Yoshiaki Gu, Nobuaki Matsunaga, Mikiyo Sakaguchi, R.N. Taichi Tajima, Norio Ohmagari, Saho Takaya, Hiroki Saito, Keiji Okinaka, Mathew Griffith, Amy Elizabeth Parry, Mateusz M Plucinski, Brenda Barnetson, James Leonard
doi: https://doi.org/10.1101/2020.05.02.20088567
Now published in The Journal of Infectious Diseases doi: 10.1093/infdis/jiaa437
Motoi Suzuki
1Infectious Disease Surveillance Centre, National Institute of Infectious Diseases, Japan
M.D., Ph.D.Hajime Kamiya
1Infectious Disease Surveillance Centre, National Institute of Infectious Diseases, Japan
M.D., Ph.D.Kiyoko Okamoto
4Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Ph.D.Takuya Yamagishi
1Infectious Disease Surveillance Centre, National Institute of Infectious Diseases, Japan
M.D., Ph.D.Kensaku Kakimoto
2Field Epidemiology Training Program, National Institute of Infectious Diseases, Japan
Ph.D.Makoto Takeda
3Department of Virology III, National Institute of Infectious Diseases, Japan
M.D., Ph.D.Syutoku Matsuyama
3Department of Virology III, National Institute of Infectious Diseases, Japan
Ph.D.Kazuya Shirato
3Department of Virology III, National Institute of Infectious Diseases, Japan
Ph.D.Naganori Nao
3Department of Virology III, National Institute of Infectious Diseases, Japan
M.D., Ph.D.Hideki Hasegawa
4Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
M.D., Ph.D.Tsutomu Kageyama
4Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Ph.D.Ikuyo Takayama
4Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Ph.D.Shinji Saito
4Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Ph.D.Takaji Wakita
5National Institute of Infectious Diseases, Japan
M.D., Ph.D.Makoto Ohnishi
5National Institute of Infectious Diseases, Japan
M.D., Ph.D.Koji Wada
6International University of Health and Welfare, Japan
M.D., Ph.D.Retsu Fujita
6International University of Health and Welfare, Japan
M.SYoshiaki Gu
7Antimicrobial Resistance Clinical Research Center, National Center for Global Health and Medicine, Japan
M.D., Ph.D., M.P.H.Nobuaki Matsunaga
7Antimicrobial Resistance Clinical Research Center, National Center for Global Health and Medicine, Japan
M.D., M.P.H., Ph.D.Mikiyo Sakaguchi
7Antimicrobial Resistance Clinical Research Center, National Center for Global Health and Medicine, Japan
R.N., M.S.N.R.N. Taichi Tajima
7Antimicrobial Resistance Clinical Research Center, National Center for Global Health and Medicine, Japan
Norio Ohmagari
8Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan
M.D., M.Sc., Ph.D.Saho Takaya
8Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan
M.D.Hiroki Saito
9Department of Emergency and Critical Care Medicine, Yokohama City Seibu Hospital, St. Marianna University School of Medicine, Japan
M.D., M.P.H.Keiji Okinaka
10Division of General Internal Medicine, National Cancer Center Hospital East, Chiba, Japan
M.D., Ph.D.Mathew Griffith
11Health Emergency Programme, World Health Organization Western Pacific Regional Office, Philippines
M.P.H.Amy Elizabeth Parry
11Health Emergency Programme, World Health Organization Western Pacific Regional Office, Philippines
GradDip PH, MAEMateusz M Plucinski
12Center for Global Health, Centers for Disease Control and Prevention, USA
Ph.D.Brenda Barnetson
13Department of Health Services, Princess Cruises, USA
M.D., M.Med.(EM), F.C.E.M.(SA)James Leonard
13Department of Health Services, Princess Cruises, USA
M.P.H., R.E.H.S.
Data Availability
All the data referred to in the manuscript are available.
Posted May 08, 2020.
Environmental sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during a coronavirus disease (COVID-19) outbreak aboard a commercial cruise ship
Motoi Suzuki, Hajime Kamiya, Kiyoko Okamoto, Takuya Yamagishi, Kensaku Kakimoto, Makoto Takeda, Syutoku Matsuyama, Kazuya Shirato, Naganori Nao, Hideki Hasegawa, Tsutomu Kageyama, Ikuyo Takayama, Shinji Saito, Takaji Wakita, Makoto Ohnishi, Koji Wada, Retsu Fujita, Yoshiaki Gu, Nobuaki Matsunaga, Mikiyo Sakaguchi, R.N. Taichi Tajima, Norio Ohmagari, Saho Takaya, Hiroki Saito, Keiji Okinaka, Mathew Griffith, Amy Elizabeth Parry, Mateusz M Plucinski, Brenda Barnetson, James Leonard
medRxiv 2020.05.02.20088567; doi: https://doi.org/10.1101/2020.05.02.20088567
Now published in The Journal of Infectious Diseases doi: 10.1093/infdis/jiaa437
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (419)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3190)
- Dermatology (269)
- Emergency Medicine (472)
- Epidemiology (13172)
- Forensic Medicine (18)
- Gastroenterology (882)
- Genetic and Genomic Medicine (5004)
- Geriatric Medicine (464)
- Health Economics (767)
- Health Informatics (3151)
- Health Policy (1118)
- Hematology (418)
- HIV/AIDS (990)
- Medical Education (466)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4754)
- Nursing (253)
- Nutrition (705)
- Oncology (2446)
- Ophthalmology (695)
- Orthopedics (273)
- Otolaryngology (335)
- Pain Medicine (317)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1270)
- Primary Care Research (541)
- Public and Global Health (7319)
- Radiology and Imaging (1643)
- Respiratory Medicine (959)
- Rheumatology (469)
- Sports Medicine (412)
- Surgery (528)
- Toxicology (68)
- Transplantation (227)
- Urology (196)